Rxo (RXO) Free Cash Flow (2021 - 2026)

Rxo (RXO) has reported Free Cash Flow for 6 consecutive years, with -$24.0 million the latest figure, recorded in Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$24.0 million, down 41.18% year-over-year; the trailing twelve-month figure through Mar 2026 was -$15.0 million (up 78.57% YoY), and the FY2025 annual result was -$8.0 million, up 85.96% from the prior year.
• Free Cash Flow was -$24.0 million for Q1 2026 at Rxo, down from -$9.0 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $91.0 million in Q1 2022 and troughed at -$24.0 million in Q1 2026.
• Average Free Cash Flow over 5 years is $11.1 million, with a median of $1.0 million recorded in 2023.
• Year-over-year, Free Cash Flow slumped 2000.0% in 2024 and jumped 156.25% in 2025.
• Over 5 years, Free Cash Flow stood at $58.0 million in 2022, then slumped by 98.28% to $1.0 million in 2023, then plunged by 2000.0% to -$19.0 million in 2024, then surged by 52.63% to -$9.0 million in 2025, then tumbled by 166.67% to -$24.0 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$24.0 million in Q1 2026, -$9.0 million in Q4 2025, and $9.0 million in Q3 2025.